INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

TNDMTANDEM DIABETES CARE INC

CIK 0001438133

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells2 / 1
Max Insider Score28
Connections4with evidence

TNDM · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
3
TJ
Twomey Christopher JDirector
TNDMTANDEM DIABETES CARE INC
Option exercise · 10b5-1 plan
M$32K
1,700 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Twomey Christopher JDirector · Oct 29, 2026
  • ← Disclosed trade inevidence
    Gilbert Ray Cisneros, Jr.Purchase disclosed 2026-10-12 · Oct 12, 2026
  • ← Lobbied forevidence
    THE NICKLES GROUP, LLCLDA Q1 2026 first quarter · Medicare/Medicaid, Budget/appropriations · Aug 26, 2026
0
TJ
Twomey Christopher JDirector
TNDMTANDEM DIABETES CARE INC
Option exercise · 10b5-1 plan
M
—
1,700 sh
Oct 27, 2026
Oct 29, 2026
traded Oct 27, 2026
+2d
SEC FORM 4

Evidence

9
TJ
Twomey Christopher JDirector
TNDMTANDEM DIABETES CARE INC
Open-market sale · 10b5-1 plan
SELL$33K
1,700 sh
Oct 27, 2026Oct 29, 2026
traded Oct 27, 2026
+2dSEC FORM 4

Evidence

20
Gilbert Ray Cisneros, Jr.DSelf
TNDMTANDEM DIABETES CARE INC
Purchase
BUY$1,001 – $15KSep 29, 2026Oct 12, 2026
traded Sep 29, 2026
+13dHOUSE PTR

Evidence

28
Gilbert Ray Cisneros, Jr.DSelf
TNDMTANDEM DIABETES CARE INC
Purchase
BUY$1,001 – $15KMar 3, 2026Apr 7, 2026
traded Mar 3, 2026
+35dHOUSE PTR

Evidence

Lobbying

$100K reported · de-duplicated
2026 Q2 $50K via firms2026 Q1 $50K via firms
  • THE NICKLES GROUP, LLC$50K2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Budget/appropriations
  • THE NICKLES GROUP, LLC$50K2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Budget/appropriations

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.